Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

Mise à jour : Il y a 4 ans
Référence : NCT01303224

Femme et Homme

Extrait

Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointestinal disorder characterised by chronic or recurrent abdominal pain or discomfort and diarrhoea. This trial aims at the evaluation of the efficacy and safety of the neurokinin type 2 receptor antagonist Ibodutant in improving IBS-D symptoms.


Critère d'inclusion

  • Irritable Bowel Syndrome With Diarrhea


Liens